bf/NYSE:AMRX_icon.png

NYSE:AMRX

Amneal Pharmaceuticals

  • Stock

USD

Last Close

11.66

06/11 21:14

Market Cap

2.19B

Beta: 1.32

Volume Today

3.12M

Avg: 1.09M

PE Ratio

151.43

PFCF: 12.36

    Description

    Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and commercializes complex oral solids, in...Show More

    Earnings

    Earnings per Share (Estimate*)

    0.10.20.30.42016-11-092018-08-092020-08-062022-08-052024-08-02

    Revenue (Estimate*)

    200M400M600M800M1B1.20B1.40B2016-11-092018-08-092020-08-062022-08-052024-08-02

    *Estimate based on analyst consensus